Literature DB >> 8189067

Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA.

J Van Damme1, P Proost, W Put, S Arens, J P Lenaerts, R Conings, G Opdenakker, H Heremans, A Billiau.   

Abstract

Monocyte chemotactic proteins (MCP) belong to a group of structurally and functionally related factors, called chemokines. To facilitate additional characterization of the recently identified MCP-2, the 76-residue protein was chemically synthesized. The synthetic 7-kDa monomeric protein was chemotactic for monocytes at 1 nM and was biochemically similar to natural MCP-2. Sensitive radioimmunoassays for both MCP-1 and MCP-2 were developed. These RIAs were specific in that no cross-reactivity could be observed, and other chemokines or cytokines were not detected. Induction of MCP-1 and MCP-2 in human diploid fibroblasts and peripheral blood leukocytes as well as osteosarcoma, epidermal carcinoma, and melanoma cells by the cytokines IL-1 beta, IFN-beta, and IFN-gamma and cytokine inducers such as dsRNA, virus, endotoxin, mitogen, and phorbol ester was studied. In connective tissue cells, IL-1 beta was the best inducer of MCP-1, but IFN-gamma was a superior inducer of MCP-2. Mononuclear cells also proved to be a source of MCP-1 and MCP-2 when stimulated by most of the inducers tested. Granulocytes, however, were inefficient producers. Measles virus induced MCP-1 and MCP-2 in most cell types. In general, the yields of MCP-2 were at least 10-fold lower than those of MCP-1. It is concluded that, although MCP-2 is often coproduced with MCP-1, regulation of expression of the two chemokines is not identical. It remains to be studied under which pathological conditions MCP-2 is released in vivo and whether MCP-1 and MCP-2 can activate different target cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189067

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice.

Authors:  Jennifer L Owen; Michael F Criscitiello; Stephania Libreros; Ramon Garcia-Areas; Kathleen Guthrie; Marta Torroella-Kouri; Vijaya Iragavarapu-Charyulu
Journal:  Cell Immunol       Date:  2011-05-10       Impact factor: 4.868

2.  Hypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblasts.

Authors:  M Galindo; B Santiago; J Alcami; M Rivero; J Martín-Serrano; J L Pablos
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

3.  The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection.

Authors:  J M Frade; M Llorente; M Mellado; J Alcamí; J C Gutiérrez-Ramos; A Zaballos; G Real; C Martínez-A
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

4.  Impact of thermal injury on wound infiltration and the dermal inflammatory response.

Authors:  Martin G Schwacha; Bjoern M Thobe; TanJanika Daniel; William J Hubbard
Journal:  J Surg Res       Date:  2010-01       Impact factor: 2.192

5.  T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.

Authors:  Peter Van Loo; Thomas Tousseyn; Vera Vanhentenrijk; Daan Dierickx; Agnieszka Malecka; Isabelle Vanden Bempt; Gregor Verhoef; Jan Delabie; Peter Marynen; Patrick Matthys; Chris De Wolf-Peeters
Journal:  Haematologica       Date:  2009-10-01       Impact factor: 9.941

6.  Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes.

Authors:  D D Taub; P Proost; W J Murphy; M Anver; D L Longo; J van Damme; J J Oppenheim
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

7.  Induction of CCL8/MCP-2 by mycobacteria through the activation of TLR2/PI3K/Akt signaling pathway.

Authors:  Haipeng Liu; Zhonghua Liu; Jianxia Chen; Ling Chen; Xin He; Ruijuan Zheng; Hong Yang; Peng Song; Dong Weng; Haili Hu; Lin Fan; Heping Xiao; Stefan H E Kaufmann; Joel Ernst; Baoxue Ge
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

8.  Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.

Authors:  Paul Proost; Sofie Struyf; Tamara Loos; Mieke Gouwy; Evemie Schutyser; René Conings; Isabelle Ronsse; Marc Parmentier; Bernard Grillet; Ghislain Opdenakker; Jan Balzarini; Jo Van Damme
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection.

Authors:  H Sprenger; R G Meyer; A Kaufmann; D Bussfeld; E Rischkowsky; D Gemsa
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

10.  Matrix Metalloproteinase-9-Generated COOH-, but Not NH2-Terminal Fragments of Serum Amyloid A1 Retain Potentiating Activity in Neutrophil Migration to CXCL8, With Loss of Direct Chemotactic and Cytokine-Inducing Capacity.

Authors:  Mieke Gouwy; Mieke De Buck; Sara Abouelasrar Salama; Jennifer Vandooren; Sofie Knoops; Noëmie Pörtner; Lotte Vanbrabant; Nele Berghmans; Ghislain Opdenakker; Paul Proost; Jo Van Damme; Sofie Struyf
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.